Cancer Research AACR Membership  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 69, 2699, April 1, 2009. Published Online First March 24, 2009;
doi: 10.1158/0008-5472.CAN-08-4359
© 2009 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
0008-5472.CAN-08-4359v1
69/7/2699    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Facompre, N.
Right arrow Articles by El-Bayoumy, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Facompre, N.
Right arrow Articles by El-Bayoumy, K.
Related Collections
Right arrow Epidemiology and Prevention
Right arrow Epidemiology and Prevention: Chemoprevention

Reviews

Potential Stages for Prostate Cancer Prevention with Selenium: Implications for Cancer Survivors

Nicole Facompre and Karam El-Bayoumy

Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Penn State Hershey Cancer Institute, Hershey, Pennsylvania

Requests for reprints: Karam El-Bayoumy, Biochemistry and Molecular Biology Department, H171, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033. Phone: 717-531-1005; Fax: 717-531-0002; E-mail: kee2{at}psu.edu.

Key Words: selenium • chemoprevention • chemotherapy • prostate • cancer survivors

The lack of treatment for "worried well" patients with high-grade prostatic intraepithelial neoplasia combined with issues of recurrence and hormone resistance in prostate cancer survivors remains a major public health obstacle. The long latency of prostate cancer development provides an ample opportunity to intervene with mechanistically based chemopreventive agents at various stages of disease progression. Our rationale for selenium intervention is based on current mechanistic knowledge derived solely from preclinical investigations. Clearly, there is sufficient scientific support for its entry into current clinical trials, the outcome of which will be highly valuable in assessing whether selenium can be recommended for cancer survivors. [Cancer Res 2009;69(7):2699–703]




This article has been cited by other articles:


Home page
Toxicol SciHome page
J. Li, J. C. Tharappel, S. G. Han, A. H. Cantor, E. Y. Lee, C. G. Gairola, and H. P. Glauert
Effect of Dietary Selenium and Cigarette Smoke on Pulmonary Cell Proliferation in Mice
Toxicol. Sci., October 1, 2009; 111(2): 247 - 253.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.